Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer - Intervention Trial 2

NCT04084249 is registered in ClinicalTrials.gov with Claus Lindbjerg Andersen as lead sponsor.

NCT NCT04084249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04084249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer - Intervention Trial 2
Lead sponsor
Claus Lindbjerg Andersen
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 1, 2020
Completion date
June 30, 2028
Enrollment
359 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

colo-rectal cancer, colonic cancer, colonic diseases, colonic neoplasms, colorectal cancer, colorectal neoplasms, ctdna, digestive system disease, digestive system neoplasm, gastro-intestinal disorder, gastrointestinal cancer, gastrointestinal neoplasms, rectal cancer, rectal diseases, rectal neoplasms